22.03.2024 / Deals & Cases

Deal: Wenger Vieli acted as Swiss legal advisor to NLS Pharmaceutics

Wenger Vieli acted as Swiss legal advisor to NLS Pharmaceutics on all Swiss legal matters in connection with the registered direct offering and concurrent private placement transaction with certain investors to issue 7,000,000 of common shares and 3,500,000 of common share warrants at a purchase price of USD 0.25 each.

The net proceeds from this transaction will be used for working capital and general corporate purposes, supporting the company's commitment to advancing its portfolio and operational capabilities.

NLS Pharmaceutics Ltd. (Nasdaq: NLSP, NLSPW) is a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system disorders.

The team was led by Pascal Honold (Partner, M&A/VC/PE) and Kevin Wilhelm Vangehr (Associate, M&A/VC/PE) and included Alessa Waibel (Senior Associate, Financial Services), Elisha Odenheimer (Associate, M&A/VC/PE) and Andrea Christen (Associate, Notarial Services).